Bio-Rad Laboratories (BIO.B) Income Statement

Bio-Rad Laboratories reported revenue of $2.58B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 0.7% from $2.57B a year earlier. Net income was $759.90M, a net margin of 29.4%. Gross margin was 51.9% and operating margin 8.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $651.00M, down 0.1% from the same quarter a year earlier.

Bio-Rad Laboratories Income Statement Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Bio-Rad Laboratories, Inc. income statement - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	2.58	2.57	2.67	2.80	2.92
Cost of Revenue	1.24	1.19	1.24	1.23	1.26
Gross Profit	1.34	1.38	1.43	1.57	1.64
Operating Expenses
Research & Development	0.28	0.30	0.24	0.26	0.25
Selling, General & Administrative	0.84	0.81	0.82	0.83	0.85
Operating Expenses	1.12	1.11	1.09	1.08	1.14
Operating Income	0.22	0.27	0.34	0.48	0.50
Other Income/Expense
Interest Income	0.10	0.08	0.10	0.06	0.02
Interest Expense	0.05	0.05	-0.05	-0.04	0.00
Other Income/Expense	0.73	-2.64	-1.19	-5.19	4.95
Income
Income Before Tax	1.00	-2.34	-0.85	-4.70	5.45
Income Tax Expense	0.24	-0.50	-0.21	-1.08	1.19
Net Income	0.76	-1.84	-0.64	-3.63	4.25
Net Income - Continuous Operations	0.76	-1.84	-0.64	-3.63	-
Net Income - Discontinued Operations	-	-	-	-	-
EBITDA	1.21	-2.14	0.51	0.62	0.70
EBIT	1.04	-2.29	0.37	0.48	0.56
Depreciation & Amortization	0.17	0.15	0.15	0.14	0.14
Earnings Per Share
Basic EPS	28.00	-65.00	-22.00	-122.00	143.00
Diluted EPS	28.00	-65.00	-22.00	-122.00	141.00
Basic Shares Outstanding	0.03	0.03	0.03	0.03	0.03
Diluted Shares Outstanding	0.03	0.03	0.03	0.03	0.03

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Bio-Rad Laboratories Financial Statements

What was Bio-Rad Laboratories's revenue in fiscal 2025?

Bio-Rad Laboratories reported revenue of $2.58B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 0.7% from $2.57B a year earlier.

Is Bio-Rad Laboratories profitable?

Yes. Bio-Rad Laboratories earned net income of $759.90M in fiscal 2025, a net margin of 29.4%. In fiscal 2024 it lost $1.84B.

What is Bio-Rad Laboratories's operating margin?

Bio-Rad Laboratories's operating income was $218.60M on revenue of $2.58B in fiscal 2025, an operating margin of 8.5%, compared with 10.5% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition